Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects

Clinical Pharmacokinetics

Volumn 51, Issue 9, 2012, Pages 553-572

  Reuter, Stephanie E ^a   Evans, Allan M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

carnitine; clinical data; levocarnitine; pharmacokinetics; pharmacology

Indexed keywords

ACYLCARNITINE; CARNITINE; COENZYME A; ESTER; PIVAMPICILLIN; VALPROIC ACID; VERAPAMIL;

ABSORPTION; AREA UNDER THE CURVE; BIOSYNTHESIS; CARNITINE DEFICIENCY; CHEMICAL STRUCTURE; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SYNTHESIS; FATTY ACID OXIDATION; HEMODIALYSIS; HOMEOSTASIS; HUMAN; KIDNEY TUBULE ABSORPTION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION; URINARY EXCRETION;

ANIMALS; CARNITINE; HOMEOSTASIS; HUMANS;

EID: 84864773894     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11633940-000000000-00000     Document Type: Review

References (233)

1. Gulewitsch W, Krimberg R. Zur kenntnis der extraktivstoffe der muskeln. II. Mitteilung.Ü ber das carnitin. Hoppe-Seyler's Z Physiol Chem 1905; 45 (3-4): 326-30
2. Tomita M, Sendju Y. Ü ber die oxyaminoverbindungen, welche die biuretreaktion zeigen. III. Spaltung der g-amino-b-oxy-buttersä ure in die optischaktiven komponenten.Hoppe-Seyler's Z Physiol Chem1927; 169 (4-6): 263-77
3. Fritz I. The effect of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol Scand 1955; 34 (4): 367-85
4. Friedman S, Fraenkel G. Reversible enzymatic acetylation of carnitine. Arch Biochem Biophys 1955; 59 (2): 491-501
5. Carter HE, Bhattacharyya PK, Weidman KR, et al. Chemical studies on vitamin BT isolation and characterization as carnitine. Arch Biochem Biophys 1952; 38: 405-16
6. Bremer J. Carnitine: metabolism and functions. Physiol Rev 1983; 63 (4): 1420-80
7. Bahl JJ, Bressler R. The pharmacology of carnitine. Annu Rev Pharmacol Toxicol 1987; 27: 257-77 (Pubitemid 17067235)
8. Choi YR, Fogle PJ, Clarke PR, et al. Quantitation of water-soluble acylcarnitines and carnitine acyltransferases in rat tissues. J Biol Chem 1977; 252 (22): 7930-1 (Pubitemid 8243666)
9. Pons R, de Vivo DC. Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995; 10 Suppl. 2: S8-24
10. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003; 41 (4 Suppl. 4): S4-12
11. Rebouche CJ, Paulson DJ. Carnitine metabolism and function in humans. Annu Rev Nutr 1986; 6: 41-66
12. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. Fromconcept tomolecular analysis. Eur J Biochem1997; 244 (1): 1-14 (Pubitemid 27079689)
13. Pande SV, Parvin R. Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well. J Biol Chem 1980; 255 (7): 2994-3001
14. Pande SV. A mitochondrial carnitine acylcarnitine translocase system. Proc Natl Acad Sci USA 1975; 72 (3): 883-7
15. Miyazawa S, Ozasa H, Osumi T, et al. Purification and properties of carnitine octanoyltransferase and carnitine palmitoyltransferase from rat liver. J Biochem 1983; 94 (2): 529-42 (Pubitemid 13018950)
16. Bieber LL. Carnitine. Annu Rev Biochem 1988; 57: 261-83
17. Ramsay RR, Arduini A. The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys 1993; 302 (2): 307-14 (Pubitemid 23212675)
18. Brass EP, Hoppel CL. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J 1980; 190 (3): 495-504
19. Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal betaoxidation. Biochim Biophys Acta 1991; 1085 (2): 141-58
20. Ramsay RR. The role of the carnitine system in peroxisomal fatty acid oxidation. Am J Med Sci 1999; 318 (1): 28-35 (Pubitemid 30387272)
21. Steiber A, Kerner J, Hoppel CL. Carnitine: A nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004; 25 (5-6): 455-73 (Pubitemid 39195071)
22. Rebouche CJ. Metabolic fate of dietary carnitine in humans. In: Carter AL, editor. Current concepts in carnitine research. Boca Raton (FL): CRC Press, 1992: 37-48
23. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004; 1033: 30-41 (Pubitemid 39656736)
24. Lombard KA, Olson AL, Nelson SE, et al. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am J Clin Nutr 1989; 50 (2): 301-6 (Pubitemid 19208747)
25. Li B, Lloyd ML, Gudjonsson H, et al. The effect of enteral carnitine administration in humans. Am J Clin Nutr 1992; 55 (4): 838-45
26. Kato Y, Sugiura M, Sugiura T, et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 2006; 70 (3): 829-37 (Pubitemid 44268440)
27. Gross CJ, Henderson LM. Absorption of D-and L-carnitine by the intestine and kidney tubule in the rat. Biochim Biophys Acta 1984; 772 (2): 209-19 (Pubitemid 14102581)
28. Shaw RD, Li BUK, Hamilton JW, et al. Carnitine transport in rat small intestine. Am J Physiol 1983; 245 (3): G376-81
29. McCloud E, Ma TY, Grant KE, et al. Uptake of L-carnitine by a human intestinal epithelial cell line, Caco-2. Gastroenterology 1996; 111 (6): 1534-40 (Pubitemid 26404217)
30. Hamilton JW, Li BUK, Shug AL, et al. Carnitine transport in human intestinal biopsy specimens: demonstration of an active transport system. Gastroenterology 1986; 91 (1): 10-6 (Pubitemid 16086648)
31. Gudjonsson H, Li BU, Shug AL, et al. In vivo studies of intestinal carnitine absorption in rats. Gastroenterology 1985; 88 (6): 1880-7 (Pubitemid 15052301)
32. Gudjonsson H, Li BUK, Shug AL, et al. Studies of carnitine metabolism in relation to intestinal absorption. Am J Physiol 1985; 248 (3): G313-9
33. Gross CJ, Savaiano DA. Effect of development and nutritional state on the uptake, metabolism and release of free and acetyl-L-carnitine by the rodent small intestine. Biochim Biophys Acta 1993; 1170 (3): 265-74 (Pubitemid 23328736)
34. Rebouche CJ, Mack DL, Edmonson PF. L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochemistry 1984; 23 (26): 6422-6 (Pubitemid 15167729)
35. Bain MA, Faull R, Milne RW, et al. Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab 2006; 7 (7): 811-6 (Pubitemid 44509682)
36. Bain MA, Fornasini G, Evans AM. Trimethylamine: metabolic, pharmacokinetic and safety aspects. Curr Drug Metab 2005; 6 (3): 227-40 (Pubitemid 40753854)
37. Rebouche CJ, Chenard CA. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr 1991; 121 (4): 539-46
38. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361 (Part 3): 417-29 (Pubitemid 34177810)
39. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J 1992; 6 (15): 3379-86 (Pubitemid 23007103)
40. Tanphaichitr V, Broquist HP. Role of lysine and e-n-trimethyllysine in carnitine biosynthesis. II: studies in the rat. J Biol Chem 1973; 248 (6): 2176-81
41. Horne DW, Broquist HP. Role of lysine and e-N-trimethyllysine in carnitine biosynthesis. I: studies in Neurospora crassa. J Biol Chem 1973; 248 (6): 2170-5
42. Hulse JD, Ellis SR, Henderson LM. Carnitine biosynthesis: betahydroxylation of trimethyllysine by an alpha-ketoglutarate-dependent mitochondrial dioxygenase. J Biol Chem 1978; 253 (5): 1654-9 (Pubitemid 8312345)
43. Sachan DS, Hoppel CL. Carnitine biosynthesis. Hydroxylation of N-6-trimethyl-lysine to 3-hydroxy-N6-trimethyl-lysine. Biochem J 1980; 188 (2): 529-34
44. Sachan DS, Broquist HP. Synthesis of carnitine from epsilon-N- trimethyllysine in post mitochondrial fractions of Neurospora crassa. Biochem Biophys Res Commun 1980; 96 (2): 870-5
45. Rebouche CJ, Bosch EP, Chenard CA, et al. Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 1989; 119 (12): 1907-13 (Pubitemid 20063884)
46. Rebouche CJ, Lehman LJ, Olson L. Epsilon-N-trimethyllysine availability regulates the rate of carnitine biosynthesis in the growing rat. J Nutr 1986; 116 (5): 751-9 (Pubitemid 16111254)
47. Rebouche CJ, Engel AG. Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta 1980; 630 (1): 22-9 (Pubitemid 10019432)
48. Hulse JD, Henderson LM. Carnitine biosynthesis: purification of 4-N'-trimethylaminobutyraldehyde dehydrogenase from beef liver. J Biol Chem 1980; 255 (3): 1146-51
49. Englard S, Blanchard JS, Midelfort CF. Gamma-butyrobetaine hydroxylase: stereochemical course of the hydroxylation reaction. Biochemistry 1985; 24 (5): 1110-6 (Pubitemid 15096759)
50. Lindstedt G, Lindstedt S. Cofactor requirements of gamma-butyrobetaine hydroxylase from rat liver. J Biol Chem 1970; 245 (16): 4178-86
51. Brass EP. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin Ther 1995; 17 (2): 176-85
52. Reuter SE, Evans AM, Chace DH, et al. Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann Clin Biochem 2008; 45 (6): 585-92
53. Niu YJ, Jiang ZM, Shu H, et al. Assay of carnitine in plasma and urine of healthy adults in Chinese; abstract. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24 (2): 185-7
54. Vinci E, Rampello E, Zanoli L, et al. Serum carnitine levels in patients with tumoral cachexia. Eur J Intern Med 2005; 16 (6): 419-23 (Pubitemid 41405711)
55. Lohninger A, Sendic A, Staniek H, et al. Endurance exercise training and L-carnitine supplementation stimulates gene expression in the blood and muscle cells in young athletes and middle aged subjects. Monatsh Chem 2005; 136 (8): 1425-42 (Pubitemid 41095370)
56. Bene J, Komlosi K, Gasztonyi B, et al. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol 2005; 11 (42): 6671-5 (Pubitemid 43072709)
57. Jones MG, Goodwin CS, Amjad S, et al. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta 2005; 360 (1-2): 173-7 (Pubitemid 41225409)
58. Wanner C, Wä ckerle B, Boeckle H, et al. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients. Am J Clin Nutr 1990; 51 (3): 407-10
59. Borum PR. Plasma carnitine compartment and red blood cell carnitine compartment of healthy adults. Am J Clin Nutr 1987; 46 (3): 437-41 (Pubitemid 18003379)
60. Furst P, Gloggler A. Reappraisal of carnitine concentrations in blood. Clin Chem 1987; 33 (10): 1956-7
61. Mayer G, Graf H, Legenstein E, et al. L-Carnitine substitution in patients on chronic hemodialysis. Nephron 1989; 52 (4): 295-9 (Pubitemid 19157061)
62. Maccari F, Hü lsmann WC. (Acyl)carnitine distribution between plasma, erythrocytes, and leukocytes in human blood letter. Clin Chem 1989; 35 (4): 711
63. Savica V, Bellinghieri G, di Stefano C, et al. Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 1983; 35 (4): 232-6 (Pubitemid 13021719)
64. Leschke M, Rumpf KW, Eisenhauer T, et al. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int 1983; 24 Suppl. 16: S143-6
65. Debska-Slizien A, Kawecka A, Wojnarowski K, et al. Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 2000; 23 (2): 90-6 (Pubitemid 30192762)
66. Bellinghieri G, Savica V, Mallamace A, et al. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38 (4): 523-31 (Pubitemid 13010197)
67. Penn D, Schmidt-Sommerfeld E. Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis. Metabolism 1983; 32 (8): 806-9 (Pubitemid 13026348)
68. Rodriguez-Segade S, Alonso de la Pena C, Paz JM, et al. Carnitine deficiency in haemodialysed patients. Clin Chim Acta 1986; 159 (3): 249-56 (Pubitemid 17171349)
69. Rodriguez-Segade S, Alonso de la Pena C, Paz M, et al. Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency. Ann Clin Biochem 1986; 23 (6): 671-5 (Pubitemid 17189152)
70. Wanner C, Fö rstner-Wanner S, Schaeffer G, et al. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 1986; 6 (3): 206-11 (Pubitemid 16022969)
71. Wanner C, Fö rstner-Wanner S, Rö ssle C, et al. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation. Kidney Int 1987; 32 Suppl. 22: S132-5
72. Segre G, Bianchi E, Corsi M, et al. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man. Arzneimittelforschung 1988; 38 (12): 1830-4 (Pubitemid 19012530)
73. Harper P, Wadström C, Cederblad G. Carnitine measurements in liver, muscle tissue, and blood in normal subjects. Clin Chem 1993; 39 (4): 592-9 (Pubitemid 23118307)
74. Golper TA, Wolfson M, Ahmad S, et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I: carnitine concentrations and lipid effects. Kidney Int 1990; 38 (5): 904-11 (Pubitemid 20362861)
75. van Es A, Henny FC, Kooistra MP, et al. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contrib Nephrol 1992; 98: 28-35
76. Marzo A, Arrigoni-Martelli E, Mancinelli A, et al. Protein binding of L-carnitine family components. Eur J Drug Metab Pharmacokinet 1991; (Spec. No. 3): 364-8
77. Cooper MB, Forte CA, Jones DA. Carnitine and acetylcarnitine in red blood cells. Biochim Biophys Acta 1988; 959 (2): 100-5 (Pubitemid 18081817)
78. Baker H, Frank O, DeAngelis B, et al. Absorption and excretion of L-carnitine during single or multiple dosings in humans. Int J Vitam Nutr Res 1993; 63 (1): 22-6
79. Reuter SE, Faull RJ, Ranieri E, et al. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24 (3): 990-6
80. Arduini A, Tyurin V, Tyuruna Y, et al. Acyl-trafficking in membrane phospholipid fatty acid turnover: the transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytes. Biochem Biophys Res Commun 1992; 187 (1): 353-8
81. Lentner C, Diem K, Seldrup J. Geigy scientific tables. 8th rev. and enl. ed. Basel: Ciba-Geigy Ltd, 1981
82. Rebouche CJ, Engel AG. Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency. In Vitro 1982; 18 (5): 495-500 (Pubitemid 12064414)
83. Willner JH, Ginsburg S, Dimauro S. Active transport of carnitine into skeletal muscle. Neurology 1978; 28 (7): 721-4 (Pubitemid 8371512)
84. Rebouche CJ. Carnitine movement across muscle cell membranes: studies in isolated rat muscle. Biochim Biophys Acta 1977; 471 (1): 145-55 (Pubitemid 8203546)
85. Martinuzzi A, Vergani L, Rosa M, et al. L-Carnitine uptake in differentiating human cultured muscle. Biochim Biophys Acta 1991; 1095 (3): 217-22
86. Angelini C, Vergani L, Martinuzzi A. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of B-oxidation. Crit Rev Clin Lab Sci 1992; 29 (3-4): 217-42 (Pubitemid 23011148)
87. Brooks DE, McIntosh JEA. Turnover of carnitine by rat tissues. Biochem J 1975; 148 (3): 439-45
88. de la Grandmaison GL, Clairand I, Durigon M. Organ weight in 684 adult autopsies: new tables for a Caucasoid population. Forensic Sci Int 2001; 119 (2): 149-54 (Pubitemid 32455488)
89. Bøhmer T, Eiklid K, Jonsen J. Carnitine uptake into human heart cells in culture. Biochim Biophys Acta 1977; 465 (3): 627-33 (Pubitemid 8052759)
90. Bahl J, Navin T, Manian AA, et al. Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8-diOH chlorpromazine. Circ Res 1981; 48 (3): 378-85 (Pubitemid 11102701)
91. Xuan W, Lamhonwah AM, Librach C, et al. Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun 2003; 306 (1): 121-8 (Pubitemid 36629414)
92. Tamai I, Ohashi R, Nezu JI, et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 2000; 275 (51): 40064-72 (Pubitemid 32064631)
93. Tamai I, Ohashi R, Nezu J, et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998; 273 (32): 20378-82 (Pubitemid 28377603)
94. Wu X, Huang W, Prasad PD, et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290 (3): 1482-92 (Pubitemid 29400294)
95. Nakanishi T, Hatanaka T, Huang W, et al. Na+-and Cl-coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed inHRPEcells and Xenopus oocytes. J Physiol 2001; 532 (Pt 2): 297-304 (Pubitemid 32390389)
96. Taylor PM. Absorbing competition for carnitine. J Physiol 2001; 532 (Pt 2): 283 (Pubitemid 32390385)
97. Tsuchida H, Anzai N, Shin HJ, et al. Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney. Cell Physiol Biochem 2010; 25 (4-5): 511-22
98. Ahmad S. Carnitine, kidney and renal dialysis. In: Ferrari R, DiMauro S, Sherwood G, editors. L-Carnitine and its role in medicine: from function to therapy. New York: Academic Press, 1992: 381-400
99. Guder WG, Wagner S. The role of the kidney in carnitine metabolism. J Clin Chem Clin Biochem 1990; 28 (5): 347-50
100. Hokland BM, Bremer J. Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney. Biochim Biophys Acta 1986; 886 (2): 223-30 (Pubitemid 16024082)
101. Suzuki Y, Masumura Y, Kobayashi A, et al. Myocardial carnitine deficiency in chronic heart failure letter. Lancet 1982; 1 (8263): 116
102. Rebouche CJ, Lombard KA, Chenard CA. Renal adaptation to dietary carnitine in humans. Am J Clin Nutr 1993; 58 (5): 660-5 (Pubitemid 23319953)
103. Rebouche CJ, Mack DL. Sodium gradient-stimulated transport of L-carnitine into renal brush bordermembrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 1984; 235 (2): 393-402 (Pubitemid 15158795)
104. Rebouche CJ. Quantitative estimation of absorption and degradation of a carnitine supplement by human adults. Metabolism 1991; 40 (12): 1305-10
105. Harper P, Elwin CE, Cederblad G. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 1988; 35 (1): 69-75
106. Huth PJ, Shug AL. Properties of carnitine transport in rat kidney cortex slices. Biochim Biophys Acta 1980; 602 (3): 621-34 (Pubitemid 11218321)
107. Brady PS, Ramsey RR, Brady LJ. Regulation of the long-chain carnitine acyltransferases. FASEB J 1993; 7 (11): 1039-44 (Pubitemid 23243446)
108. Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 2000; 95 (2): 75-83
109. Chien D, Dean D, Saha AK, et al. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinol Metab 2000; 279 (2 42-2): E259-65
110. McGarry JD, Stark MJ, Foster DW. Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. J Biol Chem 1978; 253 (22): 8291-3 (Pubitemid 9073730)
111. Peluso G, Petillo O, Margarucci S, et al. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells. J Cell Physiol 2005; 203 (2): 439-46 (Pubitemid 40471778)
112. Mancinelli A, Longo A, Shanahan K, et al. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1995; 274 (3): 1122-8
113. de Sousa C, English NR, Stacey TE, et al. Measurement of L-carnitine and acylcarnitines in body fluids and tissues in children and in adults. Clin Chim Acta 1990; 187 (3): 317-28 (Pubitemid 20100977)
114. Bøhmer T, Rydning A, Solberg HE. Carnitine levels in human serum in health and disease. Clin Chim Acta 1974; 57 (1): 55-61
115. Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972; 37: 235-43
116. McGarry JD, Foster DW. An improved and simplified radio-isotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976; 17 (3): 277-81
117. Parvin R, Pande S. Microdetermination of (-)carnitine and carnitine acetyltransferase activity. Anal Biochem 1977; 79 (1-2): 190-201 (Pubitemid 8105168)
118. Pande SV, CaramancionMN. A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Anal Biochem 1981; 112 (1): 30-8 (Pubitemid 11091239)
119. Pande SV. Radioisotopic assay of acetylcarnitine and acetyl-CoA. Methods Enzymol 1986; 123: 259-63 (Pubitemid 16045259)
120. Bieber LL, Kerner J. Short-chain acylcarnitines: identification and quantitation. Methods Enzymol 1986; 123: 264-76 (Pubitemid 16045260)
121. Kerner J, Bieber LL. A radioisotopic-exchange method for quantification of short-chain (acid-soluble) acylcarnitines. Anal Biochem 1983; 134 (2): 459-66
122. Schmidt-Sommerfeld E, Penn D, Duran M, et al. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method. J Pediatr 1993; 122 (5 I): 708-14 (Pubitemid 23134954)
123. Schmidt-Sommerfeld E, Zhang L, Bobrowski PJ, et al. Quantitation of shortand medium-chain acylcarnitines in plasma by radioisotopic exchange/highperformance liquid chromatography. Anal Biochem 1995; 231 (1): 27-33
124. Minkler PE, Hoppel CL. Quantification of free carnitine, individual shortand medium-chain acylcarnitines, and total carnitine in plasma by highperformance liquid chromatography. Anal Biochem 1993; 212 (2): 510-8 (Pubitemid 23245104)
125. Chace DH, di Perna JC, Mitchell BL, et al. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried post-mortemblood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47 (7): 1166-82 (Pubitemid 32579103)
126. Naylor EW, Chace DH. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 1999; 14 Suppl. 1: S4-8
127. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience inNSWAustralia. Acta Paediatr Suppl 1999; 88 (432): 48-51 (Pubitemid 30002611)
128. Reuter SE, Evans AM, Faull RJ, et al. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann Clin Biochem 2005; 42 (5): 387-93 (Pubitemid 41354401)
129. Minkler PE, Brass EP, Hiatt WR, et al. Quantification of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man. Anal Biochem 1995; 231 (2): 315-22
130. Angsten G, Cederblad G, Meurling S. Reference ranges for muscle carnitine concentration in children. Ann Clin Biochem 2003; 40 (Pt 4): 406-10 (Pubitemid 36819560)
131. Marquis NR, Fritz IB. The distribution of carnitine, acetylcarnitine, and carnitine acetyltransferase in rat tissues. J Biol Chem 1965; 240: 2193-6
132. Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the dog. Arch Biochem Biophys 1983; 220 (1): 60-70 (Pubitemid 13146418)
133. Lai HS, Chen Y, Chen WJ. Carnitine contents in remnant liver, kidney, and skeletal muscle after partial hepatectomy in rats: randomized trial. World J Surg 1998; 22 (1): 42-7 (Pubitemid 28027999)
134. Violante S, Ijlst L, van Lenthe H, et al. Carnitine palmitoyltransferase 2: new insights on the substrate specificity and implications for acylcarnitine profiling. Biochem Biophys Acta 2010; 1802 (9): 728-32
135. Bøhmer T, Norum KR, Bremer J. The relative amounts of long-chain acylcarnitine, acetylcarnitine, and free carnitine in organs of rats in different nutritional states and with alloxan diabetes. Biochim Biophys Acta 1966; 125 (2): 244-51
136. Faergeman NJ, Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J 1997; 323 (1): 1-12 (Pubitemid 27153867)
137. Sim KG, Hammond J, Wilcken B. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 2002; 323 (1-2): 37-58 (Pubitemid 34804794)
138. Ventura FV, Costa CG, Struys EA, et al. Quantitative acylcarnitine profiling in fibroblasts using U-13C palmitic acid: An improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 1999; 281 (1-2): 1-17 (Pubitemid 29142310)
139. Duran M, Mitchell G, de Klerk JBC. Octanoic academia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr 1985; 107 (3): 397-404 (Pubitemid 15240795)
140. Millington DS, Roe CR, Maltby DA. Characterization of new diagnostic acylcarnitines in patients with B-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomed Environm Mass Spectrom 1987; 14 (12): 711-6 (Pubitemid 17164819)
141. Morrow RJ, Rose ME. Isolation of acylcarnitines from urine: a comparison of methods and application to long-chain acyl-CoA dehydrogenase deficiency. Clin Chim Acta 1992; 211 (1-2): 73-81
142. Brown NF, Mullur RS, Subramanian I, et al. Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme. J Lipid Res 2001; 42 (7): 1134-42 (Pubitemid 32645796)
143. Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res 2011; 90 (2): 202-9
144. Marquis NR, Francesconi RP, Villee CA. A role for carnitine and long chain acylcarnitine in the regulation of lipogenesis. Adv Enzyme Regul 1968; 6 (C): 31-55
145. Martin DB, Vagelos PR. The mechanism of tricarboxylic acid cycle regulation of fatty acid synthesis. J Biol Chem 1962; 237 (6): 1787-92
146. Numa S, BortzWM, Lynen F. Regulation of fatty acid synthesis at the acetyl-CoA carboxylation step. Adv Enzyme Regul 1965; 3 (C): 407-23
147. Trumble GE, Smith MA, Winder WW. Purification and characterization of rat skeletal muscle acetyl-CoA carboxylase. Eur J Biochem 1995; 231 (1): 192-8
148. Vagelos PR, Alberts AW, Martin DB. Studies on the mechanism of activation of acetyl coenzyme A carboxylase by citrate. J Biol Chem 1963; 238 (2): 533-40
149. Scholte HR, Luyt-Houwen IE, Vaandrager-Verduin MH. The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failingmitochondria and cardiomyopathy. BasicRes Cardiol 1987; 82 Suppl. 1: 63-73 (Pubitemid 17114079)
150. Fritz IB, Hsu MP. Studies on the control of fatty acid synthesis. 1: stimulation by (+) palmitylcarnitine of fatty acid synthesis in liver preparations from fed and fasted rats. J Biol Chem 1967; 242 (5): 865-72
151. Fritz IB, Arrigoni-Martelli E. Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 1993; 14 (10): 355-60 (Pubitemid 23308758)
152. Scholte HR, Jennekens FGI, Bouvy JJBJ. Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leukocytes. J Neurol Sci 1979; 40 (1): 39-51 (Pubitemid 9030635)
153. Scholte HR, Hü lsmann WC, Luyt-Houwen IEM, et al. Carnitine palmitoyltransferase deficiencies. Biochem Soc Trans 1985; 13 (4): 643-5 (Pubitemid 15049097)
154. Echabe T, Requero MA, Goñ i FM, et al. An infrared investigation of palmitoyl-coenzyme A and palmitoylcarnitine interaction with perdeuteratedchain phospholipid bilayers. Eur J Biochem 1995; 231 (1): 199-203
155. Fritz IB, Marquis NR. The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc Natl Acad Sci USA 1965; 54 (4): 1226-33
156. Goñ i FM, Requero MA, Alonso A. Palmitoylcarnitine, a surface-active metabolite. FEBS Lett 1996; 390 (1): 1-5 (Pubitemid 26233255)
157. Requero MA, Goñ i FM, Alonso A. The membrane-perturbing properties of palmitoyl-coenzyme A and palmitoylcarnitine: a comparative study. Biochemistry 1995; 34 (3): 10400-5
158. Requero MA, Gonzales M, Goñ i FM, et al. Differential penetration of fatty acyl-coenzyme A and fatty acylcarnitines into phospholipid monolayers. FEBS Lett 1995; 357 (1): 75-8
159. Yamada KA, Kanter EM, Newatia A. Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum. J Cardiovasc Pharmacol 2000; 36 (1): 14-21 (Pubitemid 30419117)
160. Kobayashi A, Watanabe H, Fujisawa S, et al. Effects of L-carnitine and palmitoylcarnitine on membrane fluidity of human erythrocytes. Biochim Biophys Acta 1989; 986 (1): 83-8 (Pubitemid 19281626)
161. Cho KS, Proulx P. Lysis of erythrocytes by long-chain acyl esters of carnitine. Biochim Biophys Acta 1969; 193 (1): 30-5
162. Cho KS, Proulx P. Studies on the mechanism of hemolysis by acyl carnitines, lysolecithins and acyl cholines. Biochim Biophys Acta 1971; 225 (2): 214-23
163. Cho KS, Proulx P. Interactions of acyl carnitines and other lysins with erythrocytes and reconstituted erythrocyte lipoproteins. Biochim Biophys Acta 1973; 318 (1): 50-60
164. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9 (4): 311-26
165. Adams SH, Hoppel CL, Lok KH, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid B-oxidation and altered tricarboxylic acid cycle activity in type 2 diabeticAfrican-American women. JNutr 2009; 139 (6): 1073-81
166. Huffman KM, Shah SH, Stevens RD, et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 2009; 32 (9): 1678-83
167. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7 (1): 45-56
168. Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 2006; 75: 367-401 (Pubitemid 44118037)
169. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9 (3): 193-205 (Pubitemid 351301824)
170. Noland RC, Koves TR, Seiler SE, et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem 2009; 284 (34): 22840-52
171. Shah SH, Hauser ER, Bain JR, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 2009; 5 (258): 1-7
172. Tai ES, Tan ML, Stevens RD, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010; 53: 757-67
173. Redman LM, Huffman KM, Landerman LR, et al. Effect of caloric restriction with and without exercise on metabolic intermediates in nonobese men and women. J Clin Endocrinol Metab 2011; 96 (2): E312-21
174. Lum H, Sloane R, Huffman KM, et al. Plasma acylcarnitines are associated with physical performance in elderly men. J Gerontol A Biol Sci Med Sci 2011; 66A (5): 548-53
175. Ferrari R, Merli E, Cicchitelli G, et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci 2004; 1033: 79-91 (Pubitemid 39656740)
176. Palacios HH, Yendluri BB, Parvathaneni K, et al. Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets 2011; 10 (2): 149-62
177. Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev 2009; 61 (14): 1332-42
178. Goa KL, Brogden RN. L-Carnitine: a preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs 1987; 34 (1): 1-24 (Pubitemid 17092320)
179. Famularo G, Matricardi F, Nucera E, et al. Carnitine deficiency: primary and secondary syndromes. In: de Simone C, Famularo G, editors. Carnitine today. Austin (TX): RG Landes Company, 1997: 119-61
180. Rebouche CJ, Engel AG. Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 1983; 58 (8): 533-40 (Pubitemid 13044810)
181. Rodrigues Pereira R, Scholte HR, Luyt-Houwen IE, et al. Cardiomyopathy associated with carnitine loss in kidneys and small intestine. Eur J Pediatr 1988; 148: 193-7 (Pubitemid 19016134)
182. Vaz FM, Scholte HR, Ruiter J, et al. Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. Hum Genet 1999; 105 (1-2): 157-61 (Pubitemid 29396980)
183. Treem WR, Stanley CA, FinegoldDN, et al. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts.NEngl J Med 1988; 319 (20): 1331-6 (Pubitemid 19003395)
184. Tang NL, Ganapathy V, Wu X, et al. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet 1999; 8 (4): 655-60 (Pubitemid 29139980)
185. Nezu J, Tamai I, Oku A, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 1999; 21 (1): 91-4 (Pubitemid 29036290)
186. Wang Y, Ye J, Ganapathy V, et al. Mutations in the organic cation/carnitine transporterOCTN2 in primary carnitine deficiency. ProcNatlAcad SciUSA 1999; 96 (5): 2356-60 (Pubitemid 29117919)
187. Stanley CA, DeLeeuw S, Coates PM, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991; 30 (5): 709-16
188. Waber LJ, Valle D, Neill C, et al. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982; 101 (5): 700-5
189. Shapira Y, Glick B, Harel S, et al. Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine. Pediatr Neurol 1993; 9 (1): 35-8 (Pubitemid 23070094)
190. Tanphaichitr V, Leelahagul P. Carnitine metabolism and human carnitine deficiency. Nutrition 1993; 9 (3): 246-54 (Pubitemid 23183324)
191. Turnbull DM, Bartlett K, Stevens DL, et al. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med 1984; 311 (19): 1232-6 (Pubitemid 14021927)
192. Guarnieri G, Toigo G, Crapesi L, et al. Carnitine metabolism in chronic renal failure. Kidney Int 1987; 22 Suppl. 22: S116-27
193. Evans AM. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003; 41 (4 Suppl. 4): S13-26
194. Rudman D, Sewell CW, Ansley JD. Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest 1977; 60 (3): 716-23 (Pubitemid 8180876)
195. Krahenbuhl S. Carnitine metabolism in chronic liver disease. Life Sci 1996; 59 (19): 1579-99 (Pubitemid 26358289)
196. Khan L, Bamji MS. Plasma carnitine levels in children with protein-calorie malnutrition before and after rehabilitation. Clin Chim Acta 1977; 75 (1): 163-6 (Pubitemid 8030871)
197. de Simone C, Tzantzoglou S, Jirillo E, et al. L-Carnitine deficiency in AIDS patients. AIDS 1992; 6 (2): 203-5
198. Scholte HR, Stinis JT, Jennekens FG. Low carnitine levels in serum of pregnant women. N Engl J Med 1978; 299 (19): 1079-80
199. Bernardini I, Rizzo WB, Dalakas M, et al. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 1985; 75 (4): 1124-30 (Pubitemid 15087136)
200. Filipek PA, Juranek J, Nguyen MT, et al. Relative carnitine deficiency in autism. J Autism Dev Disord 2004; 34 (6): 615-23 (Pubitemid 40044667)
201. Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther 1991; 13 (1): 2-21
202. Kelly GS. L-Carnitine: therapeutic applications of a conditionally- essential amino acid. Altern Med Rev 1998; 3 (5): 345-60 (Pubitemid 128709612)
203. Reuter SE, Evans AM. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome: potential involvement of altered carnitine palmitoyltransferase-I activity. J Intern Med 2011; 270 (1): 76-84
204. Passeri M, Iannuccelli M, Ciotti G, et al. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine. Int J Clin Pharmacol Res 1988; 8 (5): 367-76
205. Passeri M, Cucinotta D, Bonati PA, et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res 1990; 10 (1-2): 75-9 (Pubitemid 20377881)
206. Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 2003; 18 (2): 61-71 (Pubitemid 36343974)
207. Wiseman LR, Brogden RN. Propionyl-L-carnitine. Drugs Aging 1998; 12 (3): 243-50
208. Brevetti G, Perna S, Sabba C, et al. Effect of propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol 1997; 79 (6): 777-80 (Pubitemid 27152336)
209. Rossini M, di Munno O, Valentini G, et al. Double-blind, multicenter trial comparing acetyl L-carnitine with placebo in the treatment of fibromyalgia patients. Clin Exp Rheumatol 2007; 25 (2): 182-8 (Pubitemid 46851421)
210. Vermeulen RCW, Scholte HR. Exploratory open label, randomized study of acetyl-and propionylcarnitine in chronic fatigue syndrome. Psychosom Med 2004; 66 (2): 276-82 (Pubitemid 38393239)
211. Ahluwalia NS, Bernad NG. A review of valproic acid-induced carnitine deficiency and replacement. J Pharm Technol 2001; 17 (3): 81-3 (Pubitemid 32476733)
212. Ohashi R, Tamai I, Yabuuchi H, et al. Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999; 291 (2): 778-84 (Pubitemid 29503553)
213. Murakami K, Sugimoto T, Woo M, et al. Effect of L-carnitine supplementation on acute valproate intoxication. Epilepsia 1996; 37 (7): 687-9 (Pubitemid 26250003)
214. Wanner C,Hö rl WH. Carnitine abnormalities in patients with renal insufficiency: pathophysiological and therapeutical aspects. Nephron 1988; 50 (2): 89-102
215. Bartel LL, Hussey JL, Shrago E. Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 1981; 34 (7): 1314-20 (Pubitemid 11054947)
216. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003; 42 (11): 941-67 (Pubitemid 37056103)
217. Bøhmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; 1 (8056): 126-8
218. Evans AM, Faull R, Fornasini G, et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 2000; 68 (3): 238-49
219. Evans AM, Faull RJ, Nation RL, et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 2004; 66 (4): 1527-34 (Pubitemid 39298386)
220. Sahajwalla CG, Helton ED, Purich ED, et al. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci 1995; 84 (5): 627-33
221. Rizza V, Lorefice R, Rizza N, et al. Pharmacokinetics of L-carnitine in human subjects. In: FerrariR, DiMauro S, Sherwood G, editors. L-Carnitine and its role in medicine: From function to therapy. London: Academic Press Limited, 1992: 63-77
222. Cao Y, Wang YX, Liu CJ, et al. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers. Clin Invest Med 2009; 32 (1): E13-9
223. Bain MA, Milne RW, Evans AM. Disposition and metabolite kinetics of oral L-carnitine in humans. J Clin Pharmacol 2006; 46 (10): 1163-70 (Pubitemid 44387416)
224. Bach AC, Schirardin H, Sihr MO, et al. Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabete Metab 1983; 9 (2): 121-4 (Pubitemid 14107970)
225. Pace S, Longo A, Toon S, et al. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption. Br J Clin Pharmacol 2000; 50 (5): 441-8
226. Kwon OS, Chung YB. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC. Arch Pharm Res 2004; 27 (6): 676-81
227. Mancinelli A, Longo A, Nation RL, et al. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver. Drug Metab Dispos 2000; 28 (12): 1401-4
228. Sahajwalla CG, Helton ED, Purich ED, et al. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose. J Pharm Sci 1995; 84 (5): 634-9
229. Uematsu T, Itaya T, Nishimoto M, et al. Pharmacokinetics and safety of L-carnitine infused i.v. in healthy subjects. Eur J Clin Pharmacol 1988; 34 (2): 213-6 (Pubitemid 18091940)
230. Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: evidence for alterations in tissue carnitine transport. J Clin Invest 1984; 73 (3): 857-67 (Pubitemid 14156870)
231. Gloggler A, Bulla M, Furst P. Kinetics of intravenously administered carnitine in haemodialysed children. J Pharm Biomed Anal 1990; 8 (5): 411-4 (Pubitemid 20311307)
232. Vernez L, Dickenmann M, Steiger J, et al. Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis. Nephrol Dial Transplant 2006; 21 (2): 450-8 (Pubitemid 43160002)
233. Fornasini G, Upton RN, Evans AM. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis. Br J Clin Pharmacol 2007; 64 (3): 335-45 (Pubitemid 47283869)